Cyclobenzaprine

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 348 publications

Low Back Pain: A Review.

Low Back Pain: A Review.

Journal: JAMA
Published: June 15, 2026

Anticholinergic Adverse Effects Associated With Skeletal Muscle Relaxants in the Intensive Care Unit.

Anticholinergic Adverse Effects Associated With Skeletal Muscle Relaxants in the Intensive Care Unit.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: May 08, 2026

Superior Oblique Myokymia Treated with Cyclobenzaprine.

Superior Oblique Myokymia Treated with Cyclobenzaprine.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: March 27, 2026

Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia.

Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: March 13, 2026

Efficacy and Safety of Pregabalin-Tizanidine vs Pregabalin in Patients with Fibromyalgia: Study Protocol for a Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded Endpoint Trial.

Efficacy and Safety of Pregabalin-Tizanidine vs Pregabalin in Patients with Fibromyalgia: Study Protocol for a Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded Endpoint Trial.

Journal: Journal of pain research
Published: February 26, 2026

Unraveling the corrosion-mitigating action of cyclobenzaprine hydrochloride on carbon steel in acidic media: integrated experimental and multiscale molecular perspectives.

Unraveling the corrosion-mitigating action of cyclobenzaprine hydrochloride on carbon steel in acidic media: integrated experimental and multiscale molecular perspectives.

Journal: Scientific reports
Published: February 06, 2026

Steady-State Pharmacokinetic Properties of TNX-102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open-Label Trial.

Steady-State Pharmacokinetic Properties of TNX-102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open-Label Trial.

Journal: Clinical pharmacology in drug development
Published: January 30, 2026

Co-occurring chronic overlapping pain conditions and pain management engagement in veterans diagnosed with fibromyalgia: A comparison of women and men.

Co-occurring chronic overlapping pain conditions and pain management engagement in veterans diagnosed with fibromyalgia: A comparison of women and men.

Journal: Pain medicine (Malden, Mass.)
Published: January 08, 2026

Sublingual cyclobenzaprine (Tonmya) for fibromyalgia.

Sublingual cyclobenzaprine (Tonmya) for fibromyalgia.

Journal: The Medical letter on drugs and therapeutics
Published: January 08, 2026

Current evidence on TNX-102 SL (cyclobenzaprine HCl sublingual) for fibromyalgia: strengths, limitations, and emerging hypotheses.

Current evidence on TNX-102 SL (cyclobenzaprine HCl sublingual) for fibromyalgia: strengths, limitations, and emerging hypotheses.

Journal: Clinical rheumatology
Published: December 01, 2025

Efficacy and safety of TNX-102 SL in patients with fibromyalgia: a systematic review and meta-analysis.

Efficacy and safety of TNX-102 SL in patients with fibromyalgia: a systematic review and meta-analysis.

Journal: Pain management
Published: October 06, 2025

Sublingual Cyclobenzaprine: First Approval.

Sublingual Cyclobenzaprine: First Approval.

Journal: Clinical drug investigation
Published: October 06, 2025
Showing 1-12 of 348

Last Updated: 06/30/2026